Press Releases on March 7, 2024 - EIN Presswire - Press Release Distribution Service

Published on March 7, 2024 - 21:01 GMT

argenx Delivers on Promise to Transform Patient Expectations in Autoimmunity at American Academy of Neurology 2024 Annual Meeting

ADHERE data presentation will highlight first potential innovation for CIDP patients in 30 years Abstracts reflect real-world value and consistent efficacy and safety profile associated with long-term use of VYVGART® and VYVGART® Hytrulo in gMG patients …

Distribution channels: Media, Advertising & PR, Technology ...

Published on March 7, 2024 - 21:01 GMT

Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update

- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response findings - - ReSTART U.S. multi-center pivotal trial currently underway - - Submitted PMDA application for recurrent Head …

Distribution channels:

Published on March 7, 2024 - 21:01 GMT

Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results

Third dosing cohort fully enrolled for our Phase 1/2 study for ONCT-534, our dual-action androgen receptor inhibitor, for the treatment of patients with advanced prostate cancer who are resistant to approved androgen receptor pathway inhibitors; initial …

Distribution channels:

Published on March 7, 2024 - 21:01 GMT

Adagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory Board

- Global oncology expert brings deep insight in colorectal cancer and role of CTLA-4 therapy as a cornerstone for combination immunotherapy - SAN DIEGO and SUZHOU, China, March 07, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company …

Distribution channels: Companies, Technology ...

Published on March 7, 2024 - 21:01 GMT

Research Frontiers Reports Fourth Quarter and Year-End 2023 Financial Results and Will Host a Conference Call at 4:30p.m. Today

WOODBURY, N.Y., March 07, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and full-year 2023. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its …

Distribution channels:

Published on March 7, 2024 - 21:01 GMT

Silvercrest Asset Management Group Inc. Reports Q4 and Year-End 2023 Results

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter and year ended December 31, 2023. Business Update After the …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on March 7, 2024 - 21:01 GMT

Lumos Pharma Reports Full Year 2023 Financial Results and Provides Clinical Development Update

End of Phase 2 Meeting to Occur in Q2 2024, Initiation of LUM-201 Phase 3 Trial Expected in Q4 2024 Previously Announced Topline Data from Phase 2 OraGrowtH210 and OraGrowtH212 Trials of LUM-201 in Moderate PGHD Met All Primary and Secondary Endpoints …

Distribution channels:

Published on March 7, 2024 - 21:01 GMT

EXL Announces Appointment of Thomas Bartlett to Board of Directors and Retirement of Board Member Som Mittal

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, announced today that Thomas Bartlett has been appointed to EXL’s board of directors as an independent director, …

Distribution channels: Companies, IT Industry ...

Published on March 7, 2024 - 21:01 GMT

Akero Therapeutics Announces Publication of Phase 2b SYMMETRY Cohort D Study in Clinical Gastroenterology and Hepatology

As reported previously, the addition of EFX to GLP-1 receptor agonist therapy had a safety and tolerability profile comparable to that of EFX alone and led to statistically significant improvements in non-invasive markers of liver injury and fibrosis and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on March 7, 2024 - 21:01 GMT

Gevo Reports Fourth Quarter and Full Year 2023 Financial Results

ENGLEWOOD, Colo., March 07, 2024 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”) today announced financial results for the fourth quarter and full year 2023 and recent corporate highlights. Recent Corporate …

Distribution channels:

Published on March 7, 2024 - 21:00 GMT

Governor Katie Hobbs Announces Fondomonte Officially No Longer Pumping Arizona Groundwater in Butler Valley

Follow Up Inspection Confirms Fondomonte No Longer Irrigating in Butler Valley Basin Phoenix, AZ – Today, Governor Katie Hobbs joined the Arizona State Land Department to announce that because of the decisive action she took in terminating and declining to …

Distribution channels:

Published on March 7, 2024 - 21:00 GMT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of RAPT Therapeutics, Inc. - RAPT

NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RAPT Therapeutics, Inc. (“RAPT” or the “Company”) (NASDAQ: RAPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or …

Distribution channels: Consumer Goods, Law ...

Published on March 7, 2024 - 21:00 GMT

Selling Tech/CRM: It's What's Below the Tip of the Iceberg That Matters Most

In today's competitive landscape, traditional tech sales methodologies fall short. Using logic helps; emotions hold the key to truly unlocking success. EVERGREEN, CO, UNITED STATES , March 7, 2024 /⁨EINPresswire.com⁩/ -- FOR IMMEDIATE RELEASE New …

Distribution channels: Book Publishing Industry, Business & Economy ...

Published on March 7, 2024 - 21:00 GMT

Inventiva announces that screening in the NATiV3, Phase III, clinical trial evaluating lanifibranor in NASH has resumed

Inventiva has lifted the voluntary pause on screening and randomization in the NATiV3 clinical trial following the approval from the US central IRB of the amended protocol and ICF. Screening of patients is resuming in sites operating under central IRB in …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 7, 2024 - 21:00 GMT

Inventiva annonce la reprise du screening dans l’étude clinique de Phase III, NATiV3, évaluant lanifibranor dans la NASH

Inventiva a levé la pause volontaire du screening et de la randomisation pour l’étude clinique NATiV3 à la suite de l’approbations par l’IRB central américain du protocole et de l’ICF amendés. Le screening des patients reprend dans les sites opérants sous …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on March 7, 2024 - 21:00 GMT

Neurona Therapeutics Announces Presentation of Updated Clinical Data at the Upcoming American Academy of Neurology (AAN) Annual ...

SAN FRANCISCO, March 07, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced that updated data from its ongoing …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on March 7, 2024 - 21:00 GMT

Doman Building Materials Reports 2023 Financial Results

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Full Year 2023 Financial Highlights(1): Revenues of $2.5 billion Gross Margin at 16 …

Distribution channels:

Published on March 7, 2024 - 20:59 GMT

Wawa Breaks Ground on First Georgia Stores; Shares Details on Expansion During Community Event 26 New Wawa Stores Planned for ...

WAWA, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- Wawa, a privately held, family-owned chain of more than 1,040 convenience retail stores currently operating in six states and Washington, D.C., is getting closer to bringing its unique food and beverage offer, …

Distribution channels: Media, Advertising & PR ...

Published on March 7, 2024 - 20:58 GMT

Mom’s Choice Award-Winning Children's Author Sharon Linen-Fordham's Inspirational Books Empower Young Minds Worldwide

Through her empowering stories, Sharon Linen-Fordham inspires and uplifts young minds worldwide, promoting kindness, courage, and self-esteem. JAMESTOWN, SOUTH CAROLINA, UNITED STATES, March 7, 2024 /⁨EINPresswire.com⁩/ -- Sharon Linen-Fordham, a …

Distribution channels: Book Publishing Industry, Culture, Society & Lifestyle ...

Published on March 7, 2024 - 20:57 GMT

USDA Assists Farmers, Ranchers and Communities Affected by Catastrophic Texas, Oklahoma Wildfires

WASHINGTON, March 7, 2024 - Agriculture Secretary Tom Vilsack has directed the U.S. Department of Agriculture (USDA) to aid recovery efforts for farmers, ranchers and residents affected by recent wildfires in the Texas panhandle and western Oklahoma. To …

Distribution channels: